Cardiorespiratory fitness is an indicator of future cardiac, metabolic, and health events and is a strong predictor of all-cause mortality. 🏃 TiffanyBrazile and colleagues review the basics of the cardiorespiratory response to exercise. Full article: eviden.cc/3Pe9Ay8

🔎🌟Today in Journal of Cardiac Failure ❤️‍🔥Cardiogenic shock in #CICU pts w/ valvular disease - Pt groups: CS caused by VHD, CS & non-causative VHD, CS w/o VHD - CS caused by VHD ➡️ unique pts, high risk of ☠️, valve intervention feasible in some w/ good outcomes! tinyurl.com/yacra5ev

Thanks Hany Ragy for posting this from the recent IMC LIVE. Here's the full clip of Andreas Gruentzig discussing "Complications" from my interview with him in 1985, just weeks before his untimely death. #AngioHistory

Justin Trudeau gives great response to Trump changing his mind on tariffs again.

WOW. Watch this. 🤯

Recognize the cute device bouncing in the LAA? Two years after transcatheter mitral paravalvular leak closure — Amplatzer device found embolized to the left atrial appendage. A reminder: closure success is more than the immediate result #CardioTwitter #StructuralHeart PCRonline 🫀

#MINT Trial (3504-pt #RCT): RESTRICTIVE transfusion is associated with MORE death or heart failure in pts who have baseline heart failure than in those without baseline heart failure! Liberal transfusion is safe in MI + anemia, EVEN with baseline HF. doi.org/10.1161/CIRCHE…

DanGer in context. Special edition of CJC on cardiogenique shock out now.

I just wrapped up 8 days attending our CICU service at Saint Luke's Mid America Heart Institute The central lesson: medicine is humbling. Stay humble. Or get humbled.

Congratulations to PI Dr. Brian J Potter, Dr. Maya Riche, Adriana Carbanaro and team at CHUM on their latest #ALLAYHF randomization! #atrialshunt #HFpEF #heartfailure #structuralheart #interventionalcardiology

Our publ in EHJ: state of the art review of intrer-atrial shunting - potentially a major breakthrough in HFrEF and selected pts with HFpEF. Add to this the ongoing placebo-procedure controlled ALLAY-HFrEF trial which has just started randomizing 350 HFrEF pts.

VA researchers have been ordered to not publish in journals without clearance from political appointees. theguardian.com/us-news/2025/j…

📚 Explore this case series on systemic sclerosis (#SSc) presenting as arrhythmogenic cardiomyopathy (#ACM), highlighting key insights to differentiate SSc-related cardiomyopathy from primary ACM ⬇️ cjcopen.ca/article/S2589-… #Cardiology #Arrhythmia #Cardiomyopathy #Myocarditis

The role of finerenone in the concomitant management of CKD-type 2 diabetes and the implication for HF prevention and treatment finerenone presents new evidence-based therapy for HFpEF/HFmrEF in addition to current application in CKD associated with T2D link.springer.com/article/10.100…

Novel risk score for Impella-HRPCI to calculate in-hospital mortality. Easy to remember and can be useful to discuss risk of mortality with patients undergoing #HRPCI. 📌 sciencedirect.com/science/articl…

More evidence that not all group 1 PH is the same. In the blue journal we show how clinical gp 1 PH with high HFpEF probability is metabolomically distinct from traditional gp 1 PH, and more similar to clinical HFpEF. atsjournals.org/doi/abs/10.116… ATS Blue Journal Mayo Clinic CV

A 🆕️ ACC Scientific Statement addresses the management of obesity in adults with #HeartFailure, with a specific focus on those with stage 2 HF with #HFpEF. Read more: bit.ly/4n0Fluh #JACC JACC Journals

🫀 A novel and improved RV-PA coupling parameter integrating all three important drivers of RV dysfunction predicts 1-year outcome after #tTEER. Read more ⬇️ onlinecjc.ca/article/S0828-… #CJC #OpenAccess

Risk Factors for Contemporary Heart Failure—Respecting the Old (Hypertension) While Accepting the New (Obesity). Hypertension is an important classic cause of HF, but obesity is equally and probably more important on a population level in the modern era authors.elsevier.com/a/1lXC65qq8fScz

Orthostatic Pulse Pressure as a Potential Indicator of Preload Insufficiency in HFpEF: Insights From PRESERVED-HF Patients with very low orthostatic PP may benefit from careful monitoring to minimize the risk of volume depletion and related complications.